Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

NHS MASKINFABRIK A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   2.9% 1.5% 1.4% 1.3% 1.3% 1.2% 8.4% 8.4%   Credit score (0-100)   59 75 77 80 80 82 29 29   Credit rating   BBB A A A A A BB BB   Credit limit (kDKK)   0.0 33.8 110.3 214.5 250.9 316.9 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   13,263 12,836 13,350 15,628 13,649 13,778 0.0 0.0   EBITDA   1,173 2,679 2,870 2,520 2,695 2,269 0.0 0.0   EBIT   -648 1,185 1,405 1,108 1,475 1,520 0.0 0.0   Pre-tax profit (PTP)   -1,390.5 435.6 805.1 583.7 728.0 653.2 0.0 0.0   Net earnings   -1,088.6 337.6 624.6 570.5 565.0 503.8 0.0 0.0   Pre-tax profit without non-rec. items   -1,390 436 805 584 728 653 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   18,719 18,321 17,241 15,774 14,681 14,511 0.0 0.0   Shareholders equity total   8,225 8,563 9,188 9,758 10,323 10,827 9,761 9,761   Interest-bearing liabilities   18,323 14,704 12,926 12,182 13,047 13,726 0.0 0.0   Balance sheet total (assets)   34,245 30,672 29,561 30,817 31,009 32,339 9,761 9,761   Net Debt   18,110 14,702 12,898 11,714 12,784 13,674 -9,761 -9,761     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   13,263 12,836 13,350 15,628 13,649 13,778 0.0 0.0   Gross profit growth   -1.4% -3.2% 4.0% 17.1% -12.7% 0.9% -100.0% 0.0%   Employees   29 25 23 24 23 24 0 0   Employee growth %   3.6% -13.8% -8.0% 4.3% -4.2% 4.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   34,245 30,672 29,561 30,817 31,009 32,339 9,761 9,761   Balance sheet change%   36.9% -10.4% -3.6% 4.2% 0.6% 4.3% -69.8% 0.0%   Added value   1,173.0 2,679.3 2,870.4 2,520.4 2,887.1 2,269.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   6,916 -2,008 -2,756 -3,090 -2,313 -919 -14,451 -66   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 1.0 2.0 3.0 4.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -4.9% 9.2% 10.5% 7.1% 10.8% 11.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -2.2% 3.7% 4.6% 4.1% 4.8% 4.8% 0.0% 0.0%   ROI %   -2.4% 4.0% 5.2% 4.7% 5.5% 5.5% 0.0% 0.0%   ROE %   -21.3% 4.0% 7.0% 6.0% 5.6% 4.8% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   24.0% 28.0% 31.1% 31.7% 33.6% 34.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   1,543.9% 548.7% 449.4% 464.8% 474.4% 602.6% 0.0% 0.0%   Gearing %   222.8% 171.7% 140.7% 124.8% 126.4% 126.8% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.5% 4.6% 4.3% 5.2% 6.0% 6.6% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.3 0.4 0.4 0.4 0.3 0.4 0.0 0.0   Current Ratio   1.3 1.5 1.4 1.4 1.4 1.4 0.0 0.0   Cash and cash equivalent   212.9 1.4 27.9 467.6 262.7 51.9 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   3,825.3 3,715.6 3,658.1 3,905.4 4,603.9 4,769.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   40 107 125 105 126 95 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   40 107 125 105 117 95 0 0   EBIT / employee   -22 47 61 46 64 63 0 0   Net earnings / employee   -38 14 27 24 25 21 0 0